Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 2, 2021Blood AdvancesOpen Access

Multiparameter phenotyping of platelet reactivity for stratification of human cohorts

View Full Paper
Ask AI
Bookmark
Share

Key result

Platelet Phenomic Analysis identifies 6 distinct platelet phenotypes beyond simple high or low reactivity.

Why the study?

Accurate assessment of platelet function may help personalize antiplatelet therapy, but existing tests are difficult to perform, unreliable, poorly standardized, and hard to analyze.

Does the Platelet Phenomic Analysis (PPAnalysis) assay enable the identification of distinct platelet function phenotypes in healthy donors?

Population

2 independent cohorts of healthy donors

Authors

JDJoanne L. DunsterUniversity of NottinghamABAlexander P. ByeUniversity of ReadingNKNeline KriekUniversity of Reading

Discussion

Loading...

Member takes

Overview

May enable detailed platelet phenotyping in research; leaves open clinical relevance or outcomes prediction in healthy donors.

Study Design

Type

Observational

Structured PICO

Does the Platelet Phenomic Analysis (PPAnalysis) assay enable the identification of distinct platelet function phenotypes in healthy donors?

P
Population
2 independent cohorts of healthy donors
I
Intervention
Platelet Phenomic Analysis (PPAnalysis) assay and associated open-source software platform
O
Outcome
Identification of subpopulations of donors with distinct platelet function phenotypessurrogate

The PPAnalysis assay provides a standardized, high-dimensional approach to phenotyping platelet reactivity, identifying 6 distinct stable phenotypes in healthy donors beyond simple 'high' and 'low' responders.

Cite This Study

Dunster et al. (2021) conducted an observational in Healthy donors. Platelet Phenomic Analysis (PPAnalysis) assay was evaluated on Platelet function phenotypes. The Platelet Phenomic Analysis assay identified 6 distinct subgroups of platelet phenotypes within 2 independent healthy cohorts, showing platelet reactivity extends beyond simple high/low categories.

synapsesocial.com/papers/6a178b905fdf2a7b88aa1f3dhttps://doi.org/10.1182/bloodadvances.2020003261
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High on-treatment platelet reactivity – definition and measurement2013 · 46 citations
  2. 2Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay2014 · 70 citations
  3. 3Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function2013 · 205 citations
  4. 4Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention2011 · 1,309 citations
  5. 5Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting2012 · 885 citations